Physician profile
Michael Sheran
NPI 1609828250
$25,729.74
in general payments reported to CMS, 2019-2025
68 companies · $2,727 in 2025
The $2,727 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,174 · 2021: $1,709 · 2022: $2,375 · 2023: $2,547 · 2024: $2,512 · 2025: $2,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,786.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $11,242.44 | 2019-2025 | |
| Viiv Healthcare Company | $2,202.18 | 2019-2025 | Dovato, Rukobia, Apretude |
| Abbvie INC. | $2,064.10 | 2019-2025 | Dalvance, Rinvoq, Vraylar |
| Astrazeneca Pharmaceuticals LP | $1,239.37 | 2019-2025 | Saphnelo, Farxiga, Breztri |
| Pfizer INC. | $744.49 | 2019-2025 | |
| Lilly USA, LLC | $700.30 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $661.92 | 2019-2025 | Pifeltro, Delstrigo, Dificid |
| Amgen INC. | $649.75 | 2019-2025 | Evenity, Prolia, Otezla |
| Glaxosmithkline, LLC. | $629.65 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $581.47 | 2019-2025 | Xifaxan |
| Novo Nordisk INC | $532.54 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $487.78 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $466.62 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $440.77 | 2019-2022 | |
| Janssen Biotech, INC. | $208.12 | 2019-2025 | Tremfya |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $205.01 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $172.35 | 2022-2025 | Rexulti, Abilify Mycite |
| Astellas Pharma US INC | $152.38 | 2021-2025 | Veozah |
| Exact Sciences Corporation | $139.55 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Harmony Biosciences LLC | $137.20 | 2023-2025 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $126.80 | 2021-2025 | Hyqvia, Cuvitru |
| Amarin Pharma, INC. | $125.06 | 2019-2020 | |
| Dexcom, INC. | $113.56 | 2021-2025 | Dexcom G6 Transmitter |
| Endo Pharmaceuticals INC. | $102.43 | 2019-2023 | Xiaflex |
| E.R. Squibb & Sons, L.L.C. | $100.19 | 2020-2023 | Eliquis |
| Sunovion Pharmaceuticals INC. | $97.39 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.60 | 2019-2022 | |
| Tetraphase Pharmaceuticals, INC. | $73.60 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $69.94 | 2024 | |
| Kyowa Kirin, INC. | $64.31 | 2023-2024 | Nourianz, Crysvita |
| Fresenius Kabi USA, LLC | $59.40 | 2023 | |
| Genzyme Corporation | $55.95 | 2020-2025 | |
| Sandoz INC. | $47.57 | 2023-2025 | Jubbonti, Hyrimoz |
| Aurinia Pharma U.S., INC. | $46.89 | 2023-2025 | Lupkynis |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.63 | 2025 | Caplyta |
| Theratechnologies INC. | $43.00 | 2019-2023 | Trogarzo, Egrifta |
| Ibsa Pharma INC. | $41.38 | 2022-2024 | Licart, Tirosint, Flector |
| Verona Pharma, INC. | $41.24 | 2025 | Ohtuvayre |
| Antares Pharma, INC. | $41.17 | 2019-2025 | Xyosted |
| Grifols USA, LLC | $40.82 | 2019-2023 | Gamunex-C |
| Endo USA, INC. | $37.93 | 2024 | Xiaflex |
| Inspire Medical Systems, INC. | $37.52 | 2024-2025 | Inspire |
| Melinta Therapeutics, LLC | $36.01 | 2021-2024 | Rezzayo, Orbactiv, Kimyrsa |
| Sobi, INC | $34.83 | 2019-2020 | |
| Recordati_rare_diseases_inc. | $34.77 | 2023-2025 | Isturisa, Signifor Lar |
| Abbott Laboratories | $33.85 | 2019-2024 | Freestyle Libre 3 |
| Eisai INC. | $32.01 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $29.09 | 2019 | |
| Hologic Sales and Service, LLC | $28.17 | 2019-2025 | Aptima |
| Sumitomo Pharma America, INC. | $28.00 | 2023 | Gemtesa |
| Almatica Pharma LLC | $24.14 | 2022 | |
| Aimmune Therapeutics, INC. | $23.26 | 2025 | Vowst |
| Seqirus USA INC | $22.58 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Indivior INC. | $21.88 | 2023 | Perseris |
| Ferring Pharmaceuticals INC. | $21.67 | 2025 | Rebyota |
| Neurocrine Biosciences, INC. | $20.59 | 2023 | Ingrezza, Ongentys |
| Ucb, INC. | $19.90 | 2025 | Bimzelx |
| Emd Serono, INC. | $19.82 | 2025 | |
| Medtronic Vascular, INC. | $19.49 | 2020 | |
| Radius Health, INC. | $17.00 | 2025 | Tymlos |
| Esperion Therapeutics, INC. | $16.79 | 2025 | Nexletol |
| Teva Pharmaceuticals USA, INC. | $14.58 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $14.09 | 2022 | |
| Medtronic, INC. | $13.57 | 2021 | |
| Avanir Pharmaceuticals, INC. | $13.07 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.38 | 2022 | |
| Arbor Pharmaceuticals, INC. | $11.77 | 2019 | |
| Collegium Pharmaceutical, INC. | $11.06 | 2021 |
Drugs and devices associated with these payments
Dovato $685Rinvoq $679Kerendia $419Rukobia $369Pifeltro $324Evenity $313Dalvance $284Saphnelo $272Eliquis $260Farxiga $259Nurtec Odt $237Delstrigo $234Xifaxan $223Prolia $222Breztri $181Dificid $147Rexulti $138Wakix $137Jardiance $133Airsupra $132Prevnar 20 $122Comirnaty $122Apretude $111Skyrizi $101Teflaro $97.13Dexcom G6 Transmitter $95.97Vraylar $95.21Cabenuva $92.59Mounjaro $92.19Ubrelvy $89.59Otezla $87.14Cologuard Collection Kit $86.86Abrysvo $85.83Paxlovid $81.86Avycaz $79.95Tzield $69.94Repatha $66.94Shingrix $63.75Arexvy $60.10Entresto $58.70Leqvio $58.70Tremfya $57.61The Cologuard Plus Collection Kit $52.69Xiaflex $51.68Zepbound $49.30Emgality $49.16Lupkynis $46.89Caplyta $46.63Fasenra $45.49Ohtuvayre $41.24Capvaxive $39.28Nourianz $37.96Inspire $37.52Trelegy Ellipta $36.35Hyqvia $35.87Evusheld $34.83Isturisa $34.77Nucala $33.26Emblaveo $32.49Veozah $31.93Kevzara $30.95Panzyga $30.85Rybelsus $29.29Ozempic $29.29Wegovy $28.56Licart $28.55Tirosint $28.55Trogarzo $28.29Egrifta $28.29Gemtesa $28.00Crysvita $26.35Amjevita $25.46Avsola $25.46Jubbonti $24.99Tavneos $23.69Vowst $23.26Gardasil 9 $23.13Gardasil $23.13Fluad Quadrivalent $22.58Hyrimoz $22.58Flucelvax Quadrivalent $22.58Freestyle Libre 3 $22.26Perseris $21.88Rebyota $21.67Gamunex-C $21.00Ingrezza $20.59Ongentys $20.59Enbrel $20.20Krystexxa $19.93Bimzelx $19.90Cuvitru $18.82Rezzayo $17.44Vabomere $17.44Kimyrsa $17.44Orbactiv $17.44Tymlos $17.00Nexletol $16.79Zavzpret $15.86Aptima $15.84Flector $15.50
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sheran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.